Jan J.G.M. Verschuuren

机构：Leiden University, Leiden University Medical Center · ORCID：0000-0002-4572-1501

发表论文 485 篇 · 总被引 28766 次 · h-index 84

代表论文

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis (2024 · Frontiers in Neurology · 被引 86)
Myasthenia gravis—Pathophysiology, diagnosis, and treatment (2024 · Handbook of clinical neurology · 被引 49)
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis (2024 · Science Translational Medicine · 被引 35)
Prevalence and incidence rates of 17 neuromuscular disorders: An updated review of the literature (2025 · Journal of Neuromuscular Diseases · 被引 22)
Efgartigimod in refractory autoimmune myasthenia gravis (2024 · Muscle & Nerve · 被引 21)
Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction (2024 · Nature Communications · 被引 16)